| Year |
Citation |
Score |
| 2019 |
Parker CJ, Desnick RJ, Bissel MD, Bloomer JR, Singal A, Gouya L, Puy H, Anderson KE, Balwani M, Phillips JD. Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. Molecular Genetics and Metabolism. PMID 31395332 DOI: 10.1016/J.Ymgme.2019.07.017 |
0.334 |
|
| 2018 |
Phillips J, Farrell C, Wang Y, Singal AK, Anderson K, Balwani M, Bissell M, Bonkovsky H, Seay T, Paw B, Desnick R, Bloomer J. Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria. Molecular Genetics and Metabolism. PMID 30391163 DOI: 10.1016/J.Ymgme.2018.10.005 |
0.305 |
|
| 2018 |
Gouya L, Bloomer J, Balwani M, Bissell DM, Rees D, Stölzel U, Phillips J, Kauppinen RK, Langendonk JL, Desnick R, Deybach JC, Bonkovsky H, Parket C, Naik H, Badminton M, et al. EXPLORE: A prospective, multinational natural history study of patients with acute hepatic porphyria with recurrent attacks Journal of Hepatology. 68. DOI: 10.1016/S0168-8278(18)30379-9 |
0.356 |
|
| 2018 |
Gouya L, Bloomer J, Balwani M, Bissell D, Rees D, Stölzel U, Phillips J, Kauppinen R, Langendonk J, Desnick R, Deybach J, Bonkovsky H, Parker C, Naik H, Badminton M, et al. An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore: A Prospective, Multinational Natural History Study of Patients with AHP Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.856 |
0.334 |
|
| 2017 |
Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, Phillips JD, Desnick RJ. Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management. Hepatology (Baltimore, Md.). PMID 28605040 DOI: 10.1002/Hep.29313 |
0.324 |
|
| 2017 |
Shoreibah MG, Venkata KV, Bloomer JR, Singal A. Obesity is Associated with Increased Mortality in Patients with Alcoholic Liver Disease Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)33833-7 |
0.328 |
|
| 2016 |
Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Kuo YF, Singal AK. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas. Annals of Hepatology. 15: 183-9. PMID 26845595 DOI: 10.5604/16652681.1193707 |
0.408 |
|
| 2016 |
Sardh E, Harper P, Al-Tawil N, Balwani M, Anderson K, Bloomer J, Bissel DM, Desnick RJ, Parker CJ, Phillips JD, Bonkovsky HL, Penz C, Chan A, Soh C, Querbes W, et al. Interim Data from a Randomized, Placebo Controlled, Phase 1 Study of Aln-AS1, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyria Blood. 128: 2318-2318. DOI: 10.1182/Blood.V128.22.2318.2318 |
0.322 |
|
| 2015 |
Raff EJ, Kakati D, Bloomer JR, Shoreibah M, Rasheed K, Singal AK. Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases. Journal of Clinical and Translational Hepatology. 3: 9-16. PMID 26356325 DOI: 10.14218/Jcth.2015.00001 |
0.38 |
|
| 2015 |
Ravi S, Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease. Digestive Diseases and Sciences. 60: 3788-93. PMID 26173506 DOI: 10.1007/S10620-015-3795-5 |
0.398 |
|
| 2014 |
Thompson MA, Redden DT, Glueckert L, Smith AB, Crawford JH, Jones KA, Eckhoff DE, Gray SH, White JA, Bloomer J, DuBay DA. Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation. Hpb Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery. 2014: 816246. PMID 25505820 DOI: 10.1155/2014/816246 |
0.304 |
|
| 2014 |
Kakati D, Raff E, Rashid K, Shoreibah M, Bloomer J, Kuo Y, Singal A. A Validated Clinical Score to Differentiate Non-Alcoholic Fatty Liver Diseases From Alcoholic Liver Disease: 594 The American Journal of Gastroenterology. 109. DOI: 10.14309/00000434-201410002-00594 |
0.352 |
|
| 2014 |
Shoreibah M, Fitzmorris P, Kuo Y, Bloomer J, Singal A. Are Cardiac Event and Cirrhosis Development Two Different Pathways in Non-Alcoholic Fatty Liver Disease?: 572 The American Journal of Gastroenterology. 109. DOI: 10.14309/00000434-201410002-00572 |
0.349 |
|
| 2014 |
Fitzmorris P, Shoreibah M, Kuo Y, Bloomer J, Singal A. Gastric Bypass Surgery Impacts Cardiac and Liver Outcomes With Better Survival in Patients With Non-Alcoholic Fatty Liver Disease: 560 The American Journal of Gastroenterology. 109. DOI: 10.14309/00000434-201410002-00560 |
0.359 |
|
| 2014 |
Shoreibah MG, Raff E, Kakati DD, Bloomer JR, Singal AK. Mo1005 Obesity and Metabolic Syndrome Are Associated With Higher Prevalence of Portal Hypertension in Alcoholic Liver Disease Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)63574-5 |
0.313 |
|
| 2014 |
Shoreibah MG, Raff E, Kakati DD, Rasheed K, Bloomer JR, Singal AK. 312 Advanced Disease With Faster Progression in Patients With Alcoholic Liver Disease Compared to Non-Alcoholic Steatohepatitis Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)63303-5 |
0.326 |
|
| 2013 |
Raff E, Kakati D, Bloomer J, Shoreibah M, Rasheed K, Singal A. Diabetes Mellitus Is an Independent Predictor of Cirrhosis and Hepatocellular Carcinoma in Patients with Steatohepatitis-Related Liver Disease: Presidential Poster: 439 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-00439 |
0.347 |
|
| 2013 |
Kakati D, Raff E, Bloomer J, Shoreibah M, Rasheed K, Singal A. A Clinical Score Predicts Non-Alcoholic Steatohepatitis-Related Liver Disease from Alcoholic Liver Disease The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-00438 |
0.347 |
|
| 2013 |
Kakati D, Raff E, Bloomer J, McGuire B, Shoreibah M, Rasheed K, Singal A. Cholecystectomy is a Predictor of Taking Liver Biopsy in Patients with Steatohepatitis-Related Liver Disease: 437 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-00437 |
0.432 |
|
| 2013 |
Rasheed K, Raff E, Kakati D, Shoreibah M, Bloomer J, Singal A. Significance of Antinuclear Antibodies in Patients with Steatohepatitis Secondary to Alcoholic Liver Disease and NASH: 436 The American Journal of Gastroenterology. 108. DOI: 10.14309/00000434-201310001-00436 |
0.363 |
|
| 2012 |
Kennedy C, Redden D, Gray S, Eckhoff D, Massoud O, McGuire B, Alkurdi B, Bloomer J, DuBay DA. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 14: 625-34. PMID 22882200 DOI: 10.1111/J.1477-2574.2012.00497.X |
0.385 |
|
| 2011 |
Bloomer JR. Exam 2: Model for End-Stage Liver Disease Score Predicts Outcome in Cirrhotic Patients During Pregnancy Clinical Gastroenterology and Hepatology. 9. DOI: 10.1016/J.Cgh.2011.06.008 |
0.326 |
|
| 2011 |
Bloomer JR. Exam 1: Legal Ramifications for Physicians of Patients Who Drive With Hepatic Encephalopathy Clinical Gastroenterology and Hepatology. 9. DOI: 10.1016/J.Cgh.2010.12.003 |
0.353 |
|
| 2010 |
Malik TA, Gutierrez AM, McGuire B, Zarzour JG, Mukhtar F, Bloomer J. Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome complicated by Crohn's disease. Digestion. 82: 24-6. PMID 20160443 DOI: 10.1159/000273735 |
0.334 |
|
| 2010 |
Bloomer JR. Exam 2: Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease Clinical Gastroenterology and Hepatology. 8. DOI: 10.1016/J.Cgh.2010.08.007 |
0.384 |
|
| 2010 |
Bloomer JR. Exam 1: Gastrointestinal and Hepatic Complications of Sickle Cell Disease Clinical Gastroenterology and Hepatology. 8. DOI: 10.1016/J.Cgh.2010.04.001 |
0.356 |
|
| 2010 |
Bloomer JR. Exam 1: Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C–Related Cirrhosis Clinical Gastroenterology and Hepatology. 8. DOI: 10.1016/J.Cgh.2009.12.003 |
0.326 |
|
| 2009 |
Bloomer JR. Exam 1: Over-the-Counter Analgesics in Cirrhosis Clinical Gastroenterology and Hepatology. 7: 913-914. DOI: 10.1016/J.Cgh.2009.07.022 |
0.34 |
|
| 2006 |
Rand EB, Bunin N, Cochran W, Ruchelli E, Olthoff KM, Bloomer JR. Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria. Pediatrics. 118: e1896-9. PMID 17074841 DOI: 10.1542/Peds.2006-0833 |
0.396 |
|
| 2006 |
Bloomer JR, Wang Y, Singhal A, Risheg H. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences. Journal of Pediatric Gastroenterology and Nutrition. 43: S36-40. PMID 16819399 DOI: 10.1097/01.Mpg.0000226388.56612.Fa |
0.315 |
|
| 2006 |
Shaw GC, Langer NB, Wang Y, Li L, Kaplan J, Bloomer JR, Paw BH. Abnormal Expression of Human Mitoferrin (SLC25A37) Is Associated with a Variant of Erythropoietic Protoporphyria. Blood. 108: 3-3. DOI: 10.1182/Blood.V108.11.3.3 |
0.336 |
|
| 2005 |
McGuire BM, Bonkovsky HL, Carithers RL, Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, Rand E, Voigt MD, Davis PR, Bloomer JR. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 11: 1590-6. PMID 16315313 DOI: 10.1002/Lt.20620 |
0.397 |
|
| 2005 |
Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria. Journal of Clinical Gastroenterology. 39. PMID 15758654 DOI: 10.1097/01.Mcg.0000155518.96629.Ea |
0.418 |
|
| 2003 |
Risheg H, Chen FP, Bloomer JR. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria. Molecular Genetics and Metabolism. 80: 196-206. PMID 14567969 DOI: 10.1016/J.Ymgme.2003.07.001 |
0.312 |
|
| 2003 |
Reddy N, Abrams G, Kunde S, Lazenby A, Jhala N, Bloomer J. The prevalence of antinuclear antibody in patients with nonalcoholic fatty liver (NAFL) Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)83759-9 |
0.377 |
|
| 2002 |
Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, Cosimi AB, Chung RT. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation. 73: 911-5. PMID 11923691 DOI: 10.1097/00007890-200203270-00014 |
0.418 |
|
| 2000 |
Bloomer JR. 18 Chronic hepatitis C and porphyria cutanea tarda Biomedical Research Reports. 2. DOI: 10.1016/S1874-5326(00)80022-8 |
0.316 |
|
| 1999 |
Abrams GA, Rose K, Fallon MB, Mcguire BM, Bloomer JR, Leeuwen DJV, Tutton T, Sellers MT, Eckhoff DE, Bynon JS. Hepatopulmonary syndrome and venous emboli causing intracerebral hemorrhages after liver transplantation: a case report. Transplantation. 68: 1809-1811. PMID 10609961 DOI: 10.1097/00007890-199912150-00028 |
0.344 |
|
| 1998 |
Scarlett YV, Brenner DA, Bloomer JR. Hepatic porphyrias. Clinics in Liver Disease. 2: 77-102, vi. PMID 15560047 DOI: 10.1016/s1089-3261(05)70365-2 |
0.441 |
|
| 1998 |
Jenkins MM, LeBoeuf RD, Ruth GR, Bloomer JR. A novel stop codon mutation (X417L) of the ferrochelatase gene in bovine protoporphyria, a natural animal model of the human disease. Biochimica Et Biophysica Acta. 1408: 18-24. PMID 9784594 DOI: 10.1016/S0925-4439(98)00052-0 |
0.304 |
|
| 1998 |
Bloomer J, Bruzzone C, Zhu L, Scarlett Y, Magness S, Brenner D. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation. The Journal of Clinical Investigation. 102: 107-14. PMID 9649563 DOI: 10.1172/Jci1347 |
0.542 |
|
| 1998 |
Bloomer JR. Liver metabolism of porphyrins and haem. Journal of Gastroenterology and Hepatology. 13: 324-9. PMID 9570250 DOI: 10.1111/J.1440-1746.1998.01548.X |
0.431 |
|
| 1998 |
McGuire BM, Bloomer JR. Complications of cirrhosis. Why they occur and what to do about them. Postgraduate Medicine. 103: 209-224. PMID 9479317 DOI: 10.3810/Pgm.1998.02.361 |
0.31 |
|
| 1997 |
Bloomer JR. Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease. The Yale Journal of Biology and Medicine. 70: 323-30. PMID 9626752 |
0.346 |
|
| 1996 |
Bloomer JR, Rank JM, Payne WD, Shover DC, Sharp HL, Zwiener RJ, Carithers RL. Follow-up after liver transplantation for protoporphyric liver disease Liver Transplantation and Surgery. 2: 269-275. PMID 9346660 DOI: 10.1002/Lt.500020404 |
0.418 |
|
| 1996 |
Potter C, Tolaymat N, Bobo R, Sharp H, Rank J, Bloomer J. Hematin therapy in children with protoporphyric liver disease Journal of Pediatric Gastroenterology and Nutrition. 23: 402-407. PMID 8956175 DOI: 10.1097/00005176-199611000-00006 |
0.401 |
|
| 1995 |
McGuire BM, Sielaff TD, Nyberg SL, Hu MY, Cerra FB, Bloomer JR. Review of Support Systems Used in the Management of Fulminant Hepatic Failure Digestive Diseases. 13: 379-388. PMID 8590524 DOI: 10.1159/000171517 |
0.393 |
|
| 1995 |
Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu WS, Cerra FB. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. Journal of Surgical Research. 59: 179-184. PMID 7630125 DOI: 10.1006/Jsre.1995.1151 |
0.378 |
|
| 1995 |
Sielaff TD, Hu MY, Rollins MD, Bloomer JR, Amiot B, Hu WS, Cerra FB. An anesthetized model of lethal canine galactosamine fulminant hepatic failure Hepatology. 21: 796-804. DOI: 10.1002/Hep.1840210329 |
0.395 |
|
| 1993 |
Rank MMDJ, Carithers R, Bloomer J. Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology. 18: 1404-1409. DOI: 10.1002/Hep.1840180619 |
0.418 |
|
| 1992 |
Key NS, Rank JM, Freese D, Bloomer JR, Hammerschmidt DE. Hemolytic anemia in protoporphyria: Possible precipitating role of liver failure and photic stress American Journal of Hematology. 39: 202-207. PMID 1546716 DOI: 10.1002/Ajh.2830390309 |
0.411 |
|
| 1991 |
Rank JM, Pascual-Leone A, Payne W, Glock M, Freese D, Sharp H, Bloomer JR. Hematin therapy for the neurologic crisis of tyrosinemia The Journal of Pediatrics. 118: 136-139. PMID 1986081 DOI: 10.1016/S0022-3476(05)81867-0 |
0.375 |
|
| 1991 |
Freese DK, Tuchman M, Schwarzenberg SJ, Sharp HL, Rank JM, Bloomer JR, Ascher NL, Payne WD. Early liver transplantation is indicated for tyrosinemia type I Journal of Pediatric Gastroenterology and Nutrition. 13: 10-15. PMID 1919940 DOI: 10.1097/00005176-199107000-00002 |
0.362 |
|
| 1990 |
Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, Snover DC. The pathology of liver allograft surving longer than one year Hepatology. 11: 465-470. PMID 2312059 DOI: 10.1002/Hep.1840110318 |
0.415 |
|
| 1990 |
Rank JM, Straka JG, Bloomer JR. Liver in disorders of porphyrin metabolism Journal of Gastroenterology and Hepatology. 5: 573-585. PMID 1966594 DOI: 10.1111/J.1440-1746.1990.Tb01443.X |
0.348 |
|
| 1989 |
Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology. 97: 188-94. PMID 2656363 DOI: 10.1016/0016-5085(89)91434-0 |
0.418 |
|
| 1989 |
Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D. Nodular regenerative hyperplasia of the liver following bone marrow transplantation Hepatology. 9: 443-448. PMID 2646196 DOI: 10.1002/Hep.1840090317 |
0.354 |
|
| 1988 |
Morton KO, Schneider F, Weimer MK, Straka JG, Bloomer JR. Hepatic and bile porphyrins in patients with protoporphyria and liver failure. Gastroenterology. 94: 1488-92. PMID 3360269 DOI: 10.1016/0016-5085(88)90690-7 |
0.442 |
|
| 1987 |
Kools AM, Bloomer JR. Abnormal liver function tests. How to assess their importance in asymptomatic patients. Postgraduate Medicine. 81: 45-51. PMID 3575198 DOI: 10.1080/00325481.1987.11699812 |
0.4 |
|
| 1987 |
Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. The American Journal of Surgical Pathology. 11: 1-10. PMID 3538917 DOI: 10.1097/00000478-198701000-00001 |
0.35 |
|
| 1987 |
Manivel JC, Bloomer JR, Snover DC. Progressive bile duct injury after thiabendazole administration Gastroenterology. 93: 245-249. PMID 3297909 DOI: 10.1016/0016-5085(87)91009-2 |
0.381 |
|
| 1987 |
Snover DC, Hutton S, Balfour HH, Bloomer JR. Cytomegalovirus infection of the liver in transplant recipients. Journal of Clinical Gastroenterology. 9: 659-665. PMID 2832467 DOI: 10.1097/00004836-198712000-00010 |
0.402 |
|
| 1986 |
Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, Claus PL. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology. 90: 2004-2007. PMID 3516787 DOI: 10.1016/0016-5085(86)90274-X |
0.385 |
|
| 1984 |
Bloomer JR, Sharp HL. The liver in Crigler-Najjar syndrome, protoporphyria, and other metabolic disorders. Hepatology (Baltimore, Md.). 4: 18S-21S. PMID 6693070 DOI: 10.1002/Hep.1840040707 |
0.39 |
|
| 1984 |
Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Orthotopic Liver Transplantation: A Pathological Study of 63 Serial Liver Biopsies from 17 Patients with Special Reference to the Diagnostic Features and Natural History of Rejection† Hepatology. 4: 1212-1222. PMID 6094331 DOI: 10.1002/Hep.1840040620 |
0.381 |
|
| 1983 |
Bloomer JR, Reuter RJ, Morton KO, Wehner JM. Enzymatic formation of zinc-protoporphyrin by rat liver and its potential effect on hepatic heme metabolism Gastroenterology. 85: 663-668. PMID 6873612 DOI: 10.1016/0016-5085(83)90023-9 |
0.36 |
|
| 1982 |
Bloomer JR, Pierach CA. Effect of hematin administration to patients with protoporphyria and liver disease. Hepatology (Baltimore, Md.). 2: 817-21. PMID 7141394 DOI: 10.1002/hep.1840020613 |
0.316 |
|
| 1982 |
Bloomer JR, Enriquez R. Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin. Gastroenterology. 82: 569-73. PMID 7054049 DOI: 10.1016/S0016-5085(82)80409-5 |
0.415 |
|
| 1981 |
Bloomer JR. Enzyme defects in the porphyrias and their relevance to the biochemical abnormalities in these disorders. The Journal of Investigative Dermatology. 77: 102-6. PMID 7252240 DOI: 10.1111/1523-1747.Ep12479280 |
0.309 |
|
| 1980 |
Brenner DA, Bloomer JR. The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts. The New England Journal of Medicine. 302: 765-9. PMID 7354807 DOI: 10.1056/Nejm198004033021401 |
0.46 |
|
| 1980 |
Brenner DA, Bloomer JR. A fluorometric assay for measurement of protoporphyrinogen oxidase activity in mammalian tissue. Clinica Chimica Acta; International Journal of Clinical Chemistry. 100: 259-66. PMID 7353311 DOI: 10.1016/0009-8981(80)90275-2 |
0.46 |
|
| 1980 |
Wolfson SJ, Allen RM, Bloomer JR. Effect of an exogenous succinyl-CoA-generating system on the measurement of delta-aminolevulinic acid synthase activity in rat liver tissue by a radiochemical assay. Biochimica Et Biophysica Acta. 611: 72-8. PMID 6766068 DOI: 10.1016/0005-2744(80)90043-1 |
0.303 |
|
| 1980 |
Bloomer JR. Serum alpha-fetoprotein in nonneoplastic liver diseases Digestive Diseases and Sciences. 25: 241-242. PMID 6156062 DOI: 10.1007/Bf01308511 |
0.341 |
|
| 1979 |
Bloomer JR. Pathogenesis and therapy of liver disease in protoporphyria. The Yale Journal of Biology and Medicine. 52: 39-48. PMID 452621 |
0.33 |
|
| 1979 |
Brenner DA, Bloomer JR. Comparison of human and bovine protoporphyria. The Yale Journal of Biology and Medicine. 52: 449-54. PMID 392959 |
0.381 |
|
| 1979 |
Kobayashi K, Allen RM, Bloomer JR, Klatskin G. Enzymatic fluorometry for estimating serum total bile acid concentration. Jama. 241: 2043-2045. DOI: 10.1001/Jama.1979.03290450041022 |
0.382 |
|
| 1977 |
Bloomer JR, Brenner DA, Mahoney MJ. Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria. The Journal of Clinical Investigation. 60: 1354-61. PMID 915001 DOI: 10.1172/JCI108895 |
0.375 |
|
| 1977 |
Brenner DA, Bloomer JR. Heme content of normal and porphyric cultured skin fibroblasts. Biochemical Genetics. 15: 1061-70. PMID 603614 DOI: 10.1007/Bf00484497 |
0.449 |
|
| 1977 |
Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. Serum α-Fetoprotein in Patients with Massive Hepatic Necrosis Gastroenterology. 72: 479-482. DOI: 10.1016/S0016-5085(77)80260-6 |
0.378 |
|
| 1976 |
Milstein HJ, Bloomer JR, Klatskin G. Serum bile acids in alcoholic liver disease. Comparison with histological features of the disease. Digestive Diseases and Sciences. 21: 281-285. PMID 1274919 DOI: 10.1007/Bf01071839 |
0.366 |
|
| 1976 |
Bloomer JR, Zaccaria J, Klatskin G. Inhibitory effects of scillaren and dinitrophenol on bilirubin excretion by the isolated perfused rat liver. Experimental Biology and Medicine. 151: 539-542. PMID 1257254 DOI: 10.3181/00379727-151-39253 |
0.354 |
|
| 1976 |
Bloomer JR. The hepatic porphyrias: pathogenesis, manifestations, and management. Gastroenterology. 71: 689-701. PMID 955357 DOI: 10.1016/S0016-5085(76)80566-5 |
0.317 |
|
| 1976 |
Bloomer JR, Allen RM, Klatskin G. Serum bile acids in primary biliary cirrhosis. Jama Internal Medicine. 136: 57-61. DOI: 10.1001/Archinte.1976.03630010041007 |
0.323 |
|
| 1975 |
Bloomer JR, Phillips MJ, Davidson DL, Klatskin G, Bloomer. Hepatic disease in erythropoietic protoporphyria. The American Journal of Medicine. 58: 869-82. PMID 1138541 DOI: 10.1016/0002-9343(75)90644-0 |
0.427 |
|
| 1975 |
Bloomer JR, Boyer JL. Phenobarbital effects in cholestatic liver disease Annals of Internal Medicine. 82: 310-317. PMID 1115464 DOI: 10.7326/0003-4819-82-3-310 |
0.438 |
|
| 1975 |
Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. Relationship of Serum α-Fetoprotein to the Severity and Duration of Illness in Patients With Viral Hepatitis Gastroenterology. 68: 342-350. DOI: 10.1016/S0016-5085(75)80017-5 |
0.392 |
|
| 1975 |
Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. α-Fetoprotein in Nonneoplastic Hepatic Disorders Jama. 233: 38-41. DOI: 10.1001/Jama.1975.03260010040018 |
0.376 |
|
| 1974 |
Klatskin G, Bloomer JR. Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits. Gastroenterology. 67: 294-302. PMID 4847709 DOI: 10.1016/S0016-5085(19)32894-X |
0.301 |
|
| 1974 |
Bloomer JR, Berk PD, Howe RB. Hepatic clearance of unconjugated bilirubin in cholestatic liver diseases Digestive Diseases and Sciences. 19: 9-14. PMID 4809035 DOI: 10.1007/Bf01073348 |
0.423 |
|
| 1973 |
Bloomer JR, Boyer JL, Klatskin G. Inhibition of bilirubin excretion in man during dehydrocholate choleresis. Gastroenterology. 65: 929-935. DOI: 10.1016/S0016-5085(19)32986-5 |
0.314 |
|
| 1972 |
Jones EA, Shrager R, Bloomer JR, Berk PD, Howe RB, Berlin NI. Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in man. The Journal of Clinical Investigation. 51: 2450-8. PMID 4639027 DOI: 10.1172/Jci107058 |
0.317 |
|
| 1971 |
Bloomer JR, Berk PD, Bonkowsky HL, Stein JA, Berlin NI, Tschudy DP. Blood volume and bilirubin production in acute intermittent porphyria. The New England Journal of Medicine. 284: 17-20. PMID 5538584 DOI: 10.1056/Nejm197101072840104 |
0.313 |
|
| 1971 |
Bloomer JR, Berk PD, Howe RB, Berlin NI. Interpretation of plasma bilirubin levels based on studies with radioactive bilirubin. Jama. 218: 216-20. PMID 4938053 DOI: 10.1001/Jama.1971.03190150036007 |
0.333 |
|
| 1970 |
Berk PD, Bloomer JR, Howe RB, Berlin NI. Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin. The American Journal of Medicine. 49: 296-305. PMID 5455561 DOI: 10.1016/S0002-9343(70)80020-1 |
0.368 |
|
| 1970 |
Berk PD, Bloomer JR, Berlin NI. Y and Z: new terms in the bilirubin equation. The New England Journal of Medicine. 283: 1166-7. PMID 4990788 DOI: 10.1056/Nejm197011192832112 |
0.362 |
|
| Show low-probability matches. |